ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,811Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 617

$444K Total Retail Price of All Prescriptions

Rank: 130 out of 617

484 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 419 368 1 3
LEVOTHYROXINE SODIUM 310 273 2 1
LISINOPRIL 276 224 3 5
METFORMIN HCL 256 219 4 9
WARFARIN SODIUM 231 191 5 7
SIMVASTATIN 224 200 6 2
METOPROLOL TARTRATE 217 189 7 11
PRAVASTATIN SODIUM 206 205 8 21
FUROSEMIDE 190 180 9 4
HYDROCHLOROTHIAZIDE 187 159 10 13
AMLODIPINE BESYLATE 178 165 11 6
POTASSIUM CHLORIDE 164 144 12 10
HYDROCODONE-ACETAMINOPHEN 157 90 S3 13 8
FENTANYL 137 59 S2 14 45
BUMETANIDE 134 105 15 124
DONEPEZIL HCL 119 119 16 30
TRAMADOL HCL 112 100 17 15
MELOXICAM 110 87 18 24
METOPROLOL SUCCINATE 110 106 18 12
ALLOPURINOL 104 92 20 27
TAMSULOSIN HCL 103 103 21 26
ATORVASTATIN CALCIUM 102 86 22 14
CITALOPRAM HBR 97 69 23 18
CARVEDILOL 89 42 24 19
ATENOLOL 85 79 25 17
POLYETHYLENE GLYCOL 3350 84 72 26 32
FLUTICASONE PROPIONATE 78 65 27 36
SPIRONOLACTONE 77 46 28 42
LOVASTATIN 75 75 29 57
GLIMEPIRIDE 74 71 30 33
ZOLPIDEM TARTRATE 72 54 31 23
ISOSORBIDE MONONITRATE ER 71 71 32 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 40 33 29
PANTOPRAZOLE SODIUM 68 61 34 37
GABAPENTIN 65 41 35 16
MIRTAZAPINE 65 65 35 50
LOSARTAN POTASSIUM 64 64 37 22
CYCLOBENZAPRINE HCL 63 13 R 38 74
NEXIUM 62 33 39 43
LANTUS 61 49 40 39
DIGOXIN 61 58 40 48
CIPROFLOXACIN HCL 59 50 42 60
NAMENDA 58 58 43 35
AZITHROMYCIN 58 50 43 70
AMOXICILLIN 57 48 45 135
GLIPIZIDE 57 57 45 82
BUSPIRONE HCL 55 24 47 131
ROPINIROLE HCL 55 55 47 66
CLONIDINE HCL 53 49 49 55
METOLAZONE 52 42 50 159
AMILORIDE-HYDROCHLOROTHIAZIDE 51 51 51 194
ENDOCET 50 0 S2 52 182
CELEBREX 50 41 52 63
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 52 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.